"They have just got OUT of the Covid antibody business. And now they watch Ellumehealth pocket 230 million dollars for going INTO the Covid antigen business".
Ellume obviously gave the subject more thought and didn't simply act in a reactionary (or speculatory) manner. One of the two know what they are doing - whilst I suspect there is a lesson to be learnt for the other one.
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer
Ann: Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer, page-12
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $3.691M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $1.92K | 240K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 925902 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 615000 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 925902 | 0.007 |
2 | 516527 | 0.006 |
3 | 1000000 | 0.005 |
3 | 1075000 | 0.004 |
2 | 766667 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 615000 | 4 |
0.013 | 750000 | 1 |
0.015 | 340000 | 2 |
0.016 | 750000 | 2 |
0.017 | 150000 | 1 |
Last trade - 10.07am 21/06/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online